Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,884,848 papers from all fields of science
Search
Sign In
Create Free Account
diperdipine
Known as:
EPDDNP
, ethyl-2-(1-piperidino)ethyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine dicarboxylate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Nitrendipine
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Experimental studies on the toxicity of diperdipine following oral and parenteral application.
R. Herzog
,
J. Leuschner
Arzneimittel-Forschung
1995
Corpus ID: 38991309
Diperdipine (ethyl-(beta-piperidinoethyl)-2,6-dimethyl-4- (3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, CAS 149543-07-7…
Expand
1992
1992
Synergistic action of postextrasystolic potentiation and diperdipine on left ventricular wall motion abnormalities in coronary heart disease.
N. Marchionni
,
F. Fantini
,
M. Maioli
,
C. Burgisser
,
G. Barletta
,
M. Di Donato
American Heart Journal
1992
Corpus ID: 25020988
1992
1992
Diperdipine: A New Dihydropyridine-type Calcium Antagonist
M. Donato
,
F. Fantini
,
N. Marchionni
1992
Corpus ID: 71202524
1991
1991
Acute hemodynamic effects of intravenous diperdipine, a new dihydropyridine derivative, in coronary heart disease.
M. Di Donato
,
M. Maioli
,
+4 authors
N. Marchionni
American Heart Journal
1991
Corpus ID: 34662682
1990
1990
Evaluation of first pass effect and biliary excretion of diperdipine in the dog
P. Greiner
,
S. Weber
,
J. Angignard
,
B. Berbey
European journal of drug metabolism and…
1990
Corpus ID: 24886629
SummaryIntravenous, oral and intraportal doses of diperdipine were given to bile duct cannulated dogs in order to assess the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required